The chemical substance with the name "(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide" and CAS number "1335210-25-7" is a complex organic compound characterized by its multi-ring structure, which includes a pyrido-pyrazine framework. This compound features multiple functional groups, including a carboxamide, dioxo groups, and a methoxy substituent, contributing to its potential biological activity. The presence of difluorophenyl and methyl groups suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its stereochemistry, indicated by the (3S,11aR) configuration, may influence its pharmacological properties and interactions with enzymes or receptors. The compound's solubility, stability, and reactivity would depend on its specific molecular interactions, which are critical for its application in drug development or as a research tool. Further studies would be necessary to elucidate its mechanism of action and potential therapeutic uses.

(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide

1335210-25-7: The chemical substance with the name "(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide" and CAS number "1335210-25-7" is a complex organic compound characterized by its multi-ring structure, which includes a pyrido-pyrazine framework. This compound features multiple functional groups, including a carboxamide, dioxo groups, and a methoxy substituent, contributing to its potential biological activity. The presence of difluorophenyl and methyl groups suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its stereochemistry, indicated by the (3S,11aR) configuration, may influence its pharmacological properties and interactions with enzymes or receptors. The compound's solubility, stability, and reactivity would depend on its specific molecular interactions, which are critical for its application in drug development or as a research tool. Further studies would be necessary to elucidate its mechanism of action and potential therapeutic uses.

CAS 1335210-25-7

(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide

Cabotegravir Impurity 18

Ref: 4Z-C-241024